Merck Serono's Dr. Pedro Hernández Quick-fire Q&A on QbD

Add bookmark
In this quick-fire Q&A, Dr. Pedro E. Hernández Director of Quality by Design at Merck Serono SA, shares his insights on Quality by Design adoption, ahead of  the 11th annual PAT and Quality by Design in Pharma conference.What is the current state of Merck Serono`s QbD adoption? Merck Serono has both a QbD policy and a QbD guide and all new development projects, small molecules and biotech, are required to follow them.   The result is a scientific, risk based approach, proactive ap...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended